Skip Navigation
Menu
Editorials |3 July 2018

When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores

Andrew Paul DeFilippis, MD, MSc; Patrick Trainor, MS, MA

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 5 June 2018.
×
FULL TEXT
Accurate estimation of cardiac risk is essential to balancing the risks and benefits of preventive therapies. Underestimation of risk results in preventable cardiovascular events, and overestimation results in unnecessary costs and exposure to treatment side effects. In 2013, the American College of Cardiology and American Heart Association published a new risk score for atherosclerotic cardiovascular disease (ASCVD) to guide risk-reducing therapy (1). However, the applicability of these new pooled cohort equations (PCEs) has been questioned because they have been found to overestimate risk (2, 3).
Yadlowsky and colleagues evaluated 2 approaches for improving the PCEs: using the same derivation method as the 2013 PCEs with updated cohort data and using both updated data and new derivation methods (4). The first approach modestly improved discrimination but did not consistently improve calibration, whereas the second approach improved both calibration and discrimination.
FULL TEXT
PDF
Not Available
Citations
Citation

DeFilippis AP, Trainor P. When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores. Ann Intern Med. ;169:56–57. doi: 10.7326/M18-1175

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2018;169(1):56-57.

DOI: 10.7326/M18-1175

Published at www.annals.org on 5 June 2018

©
2018 American College of Physicians
0 Citations

Related Articles
Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position: A Retrospective Cohort Study
Annals of Internal Medicine; 167 (7): 456-464
Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys
Annals of Internal Medicine; 166 (12): 876-882
Annals for Educators - 17 January 2017
Annals of Internal Medicine; 166 (2): ED2
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Annals of Internal Medicine; 131 (5): 363-375
View MoreView Less

Journal Club
Liraglutide reduced a composite renal outcome at a median 4 y in patients with type 2 diabetes and high CV risk
Annals of Internal Medicine; 167 (12): JC66
Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk
Annals of Internal Medicine; 166 (2): JC8
In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y
Annals of Internal Medicine; 165 (8): JC38
Rosuvastatin reduced major cardiovascular events in patients at intermediate cardiovascular risk
Annals of Internal Medicine; 165 (2): JC6
View MoreView Less

Related Point of Care
Peripheral Arterial Disease
Annals of Internal Medicine; 146 (5): ITC3-1
View MoreView Less

Related Topics
Cardiology
Coronary Risk Factors
Prevention/Screening

Cardiology, Coronary Risk Factors, Prevention/Screening.

PubMed Articles
Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis.
FEBS J 2019.
Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP.
Rheumatology (Oxford) 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×